Understanding Radioactive Iodine-Refractory Differentiated Thyroid Cancer (RAI-R-DTC) - Episode 4

Common Molecular Alterations in Advanced RAI-R-DTC

Dr Lori Wirth details the common molecular alterations seen in patients with advanced RAO-R-DTC and which testing platforms she recommends.

EP. 1: Defining Differentiated Thyroid Cancer (DTC) and Radioactive Iodine-Refractory Differentiated Thyroid Cancer (DAI-R-DTC)
EP. 2: Standard of Care Treatment for Patients with Advanced RAI-R-DTC
EP. 3: Review of Clinical Trial Data Investigating the Treatment of Advanced RAI-R-DTC
Now Viewing
EP. 4: Common Molecular Alterations in Advanced RAI-R-DTC
EP. 5: The Impact of Molecular Alterations in Advanced RAI-R-DTC Treatment Decision-Making
EP. 6: Unmet Needs for Patients With Advanced RAI-R-DTC